High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial

Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
doi: https://doi.org/10.1101/2021.09.15.21263597

Article usage

Article usage: September 2021 to May 2025

AbstractFullPdf
Sep 2021171031298
Oct 20213809295
Nov 20212432474
Dec 2021172590
Jan 2022951156
Feb 202266029
Mar 202295934
Apr 202255417
May 202261115
Jun 202257618
Jul 202260114
Aug 202259221
Sep 202265015
Oct 202253115
Nov 202236117
Dec 202232116
Jan 202345428
Feb 202343514
Mar 20232215
Apr 202332625
May 202329111
Jun 202323412
Jul 202314213
Aug 2023321313
Sep 202332516
Oct 202322213
Nov 202332109
Dec 202320311
Jan 20241227
Feb 202418417
Mar 20241728
Apr 202415616
May 202424113
Jun 202420213
Jul 202419416
Aug 202424721
Sep 202417113
Oct 202416418
Nov 202436219
Dec 202426016
Jan 202533320
Feb 2025181715
Mar 2025442018
Apr 202541522
May 20251259
Back to top
Posted September 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
medRxiv 2021.09.15.21263597; doi: https://doi.org/10.1101/2021.09.15.21263597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area